Cargando…
The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding
Recent interest in transfusion management of trauma patients has heightened expectation in the role of blood component therapy in improving patient outcome. Optimal transfusion support in supplementation with fibrinogen has not been defined by high-quality evidence. Current evidence comes mainly fro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388654/ https://www.ncbi.nlm.nih.gov/pubmed/22082120 http://dx.doi.org/10.1186/cc10510 |